MicroRNA 133A Regulates Cell Proliferation, Cell Migration, and Apoptosis in Colorectal Cancer by Suppressing CDH3

Grinsun Sharma1, Ji-Su Mo2, Santosh Lamichhane1

  • 1Department of Pathology, School of Medicine, Wonkwang University, Iksan, Chonbuk 54538, Republic of Korea.

Journal of Cancer
|May 8, 2023
PubMed

Insights

MicroRNA-133a (MIR133A) directly targets Cadherin 3 (CDH3) in colorectal cancer. This interaction suppresses tumor growth and metastasis by regulating key cellular pathways.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • MicroRNAs are crucial regulators in cancer development.
  • Colorectal carcinoma (CRC) pathogenesis involves complex gene regulation.
  • Identifying microRNA targets is key to understanding cancer mechanisms.

Purpose of the Study:

  • To identify and validate direct target genes of MIR133A in colorectal cancer.
  • To elucidate the functional role of the MIR133A-CDH3 interaction in CRC.
  • To investigate the impact of this interaction on cancer cell behavior.

Main Methods:

  • Luciferase reporter assays to confirm direct targeting.
  • Quantitative RT-PCR and Western blot to assess gene and protein expression.
  • Transfection with MIR133A mimics and CDH3 siRNAs in CRC cell lines.
  • Immunohistochemistry to evaluate CDH3 expression in tumor tissues.

Main Results:

  • Cadherin 3 (CDH3) was confirmed as a direct target of MIR133A.
  • MIR133A transfection significantly reduced CDH3 mRNA and protein levels in CRC cells.
  • CDH3 knockdown mimicked the effects of MIR133A, reducing cell viability, migration, and colony formation while increasing apoptosis.
  • CDH3 protein expression was upregulated in CRC tissues compared to adjacent non-tumor tissues.
  • MIR133A regulated pathways including catenin, matrix metalloproteinase, apoptosis, and epithelial-mesenchymal transition (EMT).

Conclusions:

  • MIR133A directly targets and downregulates CDH3 expression in human colorectal cancer.
  • The MIR133A-CDH3 axis plays a significant role in regulating CRC cell proliferation, migration, and apoptosis.
  • MIR133A acts as a tumor suppressor in CRC by inhibiting CDH3-mediated pathways.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.5K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.3K